Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. 1976

J A Gottlieb, and R S Benjamin, and L H Baker, and R M O'Bryan, and J G Sinkovics, and B Hoogstraten, and J M Quagliana, and S E Rivkin, and G P Bodey, and V Rodriguez, and G R Blumenschein, and J H Saiki, and C Coltman, and M A Burgess, and P Sullivan, and T Thigpen, and R Bottomley, and S Balcerzak, and T E Moon

DTIC was one of the first of several new agents evaluated by the Southwest Oncology Group (SWOG) and the M.D. Anderson Hospital and Tumor Institute (MDAH) in the therapy of adult patients with metastatic sarcomas. It yielded an overall response rate of 17%. This is similar to that seen in a review of 138 patients who represent the total number reported in either published or unpublished data. The subsequent addition of DTIC to adriamycin in several studies carried out at the MDAH and in the SWOG has increased the complete and partial remission rate over that seen with adriamycin alone, and more importantly has increased remission duration and survival. DTIC is currently used in combination with adriamycin in the first-line therapy of patients with metastatic sarcomas and should be considered for patients who have relapsed on primary therapy not including DTIC.

UI MeSH Term Description Entries
D007890 Leiomyosarcoma A sarcoma containing large spindle cells of smooth muscle. Although it rarely occurs in soft tissue, it is common in the viscera. It is the most common soft tissue sarcoma of the gastrointestinal tract and uterus. The median age of patients is 60 years. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1865) Leiomyosarcoma, Epithelioid,Leiomyosarcoma, Myxoid,Epithelioid Leiomyosarcoma,Epithelioid Leiomyosarcomas,Leiomyosarcomas,Leiomyosarcomas, Epithelioid,Leiomyosarcomas, Myxoid,Myxoid Leiomyosarcoma,Myxoid Leiomyosarcomas
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003606 Dacarbazine An antineoplastic agent. It has significant activity against melanomas. (from Martindale, The Extra Pharmacopoeia, 31st ed, p564) DTIC,5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide,Biocarbazine,DIC,DTIC-Dome,Decarbazine,Deticene,Dimethyl Imidazole Carboxamide,Dimethyl Triazeno Imidazole Carboxamide,ICDT,NSC-45388,Carboxamide, Dimethyl Imidazole,DTIC Dome,DTICDome,Imidazole Carboxamide, Dimethyl,NSC 45388,NSC45388
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012509 Sarcoma A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant. Sarcoma, Epithelioid,Sarcoma, Soft Tissue,Sarcoma, Spindle Cell,Epithelioid Sarcoma,Epithelioid Sarcomas,Sarcomas,Sarcomas, Epithelioid,Sarcomas, Soft Tissue,Sarcomas, Spindle Cell,Soft Tissue Sarcoma,Soft Tissue Sarcomas,Spindle Cell Sarcoma,Spindle Cell Sarcomas
D014226 Triazenes Compounds with three contiguous nitrogen atoms in linear format, H2N-N Diazoamino Compounds,Compounds, Diazoamino

Related Publications

J A Gottlieb, and R S Benjamin, and L H Baker, and R M O'Bryan, and J G Sinkovics, and B Hoogstraten, and J M Quagliana, and S E Rivkin, and G P Bodey, and V Rodriguez, and G R Blumenschein, and J H Saiki, and C Coltman, and M A Burgess, and P Sullivan, and T Thigpen, and R Bottomley, and S Balcerzak, and T E Moon
March 1976, Cancer treatment reports,
J A Gottlieb, and R S Benjamin, and L H Baker, and R M O'Bryan, and J G Sinkovics, and B Hoogstraten, and J M Quagliana, and S E Rivkin, and G P Bodey, and V Rodriguez, and G R Blumenschein, and J H Saiki, and C Coltman, and M A Burgess, and P Sullivan, and T Thigpen, and R Bottomley, and S Balcerzak, and T E Moon
February 1976, Cancer treatment reports,
J A Gottlieb, and R S Benjamin, and L H Baker, and R M O'Bryan, and J G Sinkovics, and B Hoogstraten, and J M Quagliana, and S E Rivkin, and G P Bodey, and V Rodriguez, and G R Blumenschein, and J H Saiki, and C Coltman, and M A Burgess, and P Sullivan, and T Thigpen, and R Bottomley, and S Balcerzak, and T E Moon
February 1976, Cancer treatment reports,
J A Gottlieb, and R S Benjamin, and L H Baker, and R M O'Bryan, and J G Sinkovics, and B Hoogstraten, and J M Quagliana, and S E Rivkin, and G P Bodey, and V Rodriguez, and G R Blumenschein, and J H Saiki, and C Coltman, and M A Burgess, and P Sullivan, and T Thigpen, and R Bottomley, and S Balcerzak, and T E Moon
February 1976, Cancer treatment reports,
J A Gottlieb, and R S Benjamin, and L H Baker, and R M O'Bryan, and J G Sinkovics, and B Hoogstraten, and J M Quagliana, and S E Rivkin, and G P Bodey, and V Rodriguez, and G R Blumenschein, and J H Saiki, and C Coltman, and M A Burgess, and P Sullivan, and T Thigpen, and R Bottomley, and S Balcerzak, and T E Moon
February 1976, Cancer treatment reports,
J A Gottlieb, and R S Benjamin, and L H Baker, and R M O'Bryan, and J G Sinkovics, and B Hoogstraten, and J M Quagliana, and S E Rivkin, and G P Bodey, and V Rodriguez, and G R Blumenschein, and J H Saiki, and C Coltman, and M A Burgess, and P Sullivan, and T Thigpen, and R Bottomley, and S Balcerzak, and T E Moon
February 1976, Cancer treatment reports,
J A Gottlieb, and R S Benjamin, and L H Baker, and R M O'Bryan, and J G Sinkovics, and B Hoogstraten, and J M Quagliana, and S E Rivkin, and G P Bodey, and V Rodriguez, and G R Blumenschein, and J H Saiki, and C Coltman, and M A Burgess, and P Sullivan, and T Thigpen, and R Bottomley, and S Balcerzak, and T E Moon
February 1976, Cancer treatment reports,
J A Gottlieb, and R S Benjamin, and L H Baker, and R M O'Bryan, and J G Sinkovics, and B Hoogstraten, and J M Quagliana, and S E Rivkin, and G P Bodey, and V Rodriguez, and G R Blumenschein, and J H Saiki, and C Coltman, and M A Burgess, and P Sullivan, and T Thigpen, and R Bottomley, and S Balcerzak, and T E Moon
February 1976, Cancer treatment reports,
J A Gottlieb, and R S Benjamin, and L H Baker, and R M O'Bryan, and J G Sinkovics, and B Hoogstraten, and J M Quagliana, and S E Rivkin, and G P Bodey, and V Rodriguez, and G R Blumenschein, and J H Saiki, and C Coltman, and M A Burgess, and P Sullivan, and T Thigpen, and R Bottomley, and S Balcerzak, and T E Moon
February 1976, Cancer treatment reports,
J A Gottlieb, and R S Benjamin, and L H Baker, and R M O'Bryan, and J G Sinkovics, and B Hoogstraten, and J M Quagliana, and S E Rivkin, and G P Bodey, and V Rodriguez, and G R Blumenschein, and J H Saiki, and C Coltman, and M A Burgess, and P Sullivan, and T Thigpen, and R Bottomley, and S Balcerzak, and T E Moon
February 1976, Cancer treatment reports,
Copied contents to your clipboard!